REPS1
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| RALBP1 associated Eps domain containing 1 | MIM:614825 | Ensembl:ENSG00000135597 | HGNC:HGNC:15578 | PA34329 | 6q24.1 |
GO terms in REPS1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0005509 | calcium ion binding |
| MF | IPI | GO:0005515 | protein binding |
| MF | IPI | GO:0017124 | SH3 domain binding |
| BP | IEA | GO:0006898 | receptor-mediated endocytosis |
| BP | TAS | GO:0061024 | membrane organization |
| CC | TAS | GO:0005829 | cytosol |
| CC | IDA | GO:0005886 | plasma membrane |
| CC | IDA | GO:0005905 | clathrin-coated pit |
Gene expression in normal tissue: REPS1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in REPS1
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-199991 | Membrane Trafficking |
| reactome | R-HSA-5653656 | Vesicle-mediated transport |
| reactome | R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis |
| reactome | R-HSA-8856828 | Clathrin-mediated endocytosis |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD144 | NSC95397 | 3 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD772 | BRD4770 | 3 |
| iGMDRD607 | Ubistatin B | 3 |
| iGMDRD889 | Compound 7d-cis | 3 |
| iGMDRD237 | ABT-751 | 4 |
| iGMDRD152 | 179324-69-7 | 4 |
| iGMDRD57 | Chloropentafluorobenzene | 6 |
| iGMDRD171 | Pemetrexed | 3 |
| iGMDRD6 | AM-580 | 2 |
| iGMDRD221 | Tamoxifen | 2 |
| iGMDRD77 | Itraconazole | 3 |
| iGMDRD441 | TW 37 | 2 |
| iGMDRD121 | GMX1778 | 2 |
| iGMDRD872 | BRD7137 | 2 |
| iGMDRD414 | MST-312 | 2 |
| iGMDRD286 | Nsc 632839 | 2 |
| iGMDRD100 | Zebularine | 3 |
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD67 | PENFLURIDOL | 5 |
| iGMDRD398 | Sepantronium | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in REPS1

